EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Repositioning anthelmintics for the treatment of inflammatory-based pathological conditions

Débora Caroline do Nascimento Rodrigues, Jhonatas Cley Santos Porto, Ingredy Lopes Dos Santos, José Ivo Araújo Beserra Filho, Paulo Michel Pinheiro Ferreira

Inflammopharmacology · 2025-02 · 33 (2) · 551-571

DOI: 10.1007/s10787-024-01605-w ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Inflammopharmacology, online erschienen am 26.11.2024. Verfasst von Débora Caroline do Nascimento Rodrigues und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Experimental Cancerology (LabCancer), Department of Biophysics and Physiology, Center for Health Sciences, Federal University of Piauí …. Hauptthemen laut MEDLINE: Inflammation, Anthelmintics, Drug Repositioning, Anti-Inflammatory Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 136 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute, uncontrolled and/or long-lasting inflammation causes a breakdown in immunological tolerance, leading to chronicity and contributing to a series of significant local or systemic tissue changes. Anti-inflammatory efficacy, fewer adverse effects, improved selectivity, and curative action are imminent issues for patients suffering from chronic inflammation-related pathologies. Then, we performed a complete and critical review about anthelmintics, discussing the main classes and the available preclinical evidence on repurposing to treat inflammation-based conditions. Despite low bioavailability, many benzimidazoles (albendazole and mebendazole), salicylanilides (niclosamide), macrocyclic lactones (avermectins), pyrazinoisoquinolones (praziquantel), thiazolides (nitazoxanide), piperazine derivatives, and imidazothiazoles (levamisole) indicate that repositioning is a promising strategy. They may represent a lower cost and time-saving course to expand anti-inflammatory options. Although mechanisms of action are not fully elucidated and well-delineated, in general, anthelmintics disrupt mitogen-activated protein kinases, the synthesis of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-8, IL-12, and IFN-γ), the migration and infiltration of leukocytes, and decrease COX-2 expression, which impacts negatively on the release of prostanoids and leukotrienes. Moreover, some of them reduce nuclear accumulation of NF-κB (niclosamide, albendazole, and ivermectin), levels of nitric oxide (nitazoxanide and albendazole), and mucus, cytokines, and bronchoconstriction in experimental inflammatory pulmonary diseases (ivermectin and niclosamide). Considering the linking between cytokines, bradykinin, histamine, and nociceptors with algesia, anthelmintics also stand out for treating inflammatory pain disorders (ivermectin, niclosamide, nitazoxanide, mebendazole, levamisole), including for cancer-related pain status. There are obstacles, including the low bioavailability and the first-pass metabolism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InflammationAnthelminticsDrug RepositioningAnti-Inflammatory AgentsHumansAnimalsCytokines

Stichwörter der Autor:innen

Antinociceptive activityBioavailabilityHyperalgesiaImmunomodulatory effectsPro-inflammatory cytokines

Substanzen

AnthelminticsAnti-Inflammatory AgentsCytokines

Autor:innen und Institutionen

  • Laboratory of Experimental Cancerology (LabCancer), Department of Biophysics and Physiology, Center for Health Sciences, Federal University of Piauí (UFPI), Universitaria Avenue, Teresina, Piauí, 64049-550, Brazil.
  • Laboratory of Experimental Cancerology (LabCancer), Department of Biophysics and Physiology, Center for Health Sciences, Federal University of Piauí (UFPI), Universitaria Avenue, Teresina, Piauí, 64049-550, Brazil. pmpf…

Zitieren

APA

Rodrigues, D. C. D. N., Porto, J. C. S., Dos Santos, I. L., Filho, J. I. A. B., & Ferreira, P. M. P. (2025). Repositioning anthelmintics for the treatment of inflammatory-based pathological conditions. Inflammopharmacology, 33(2), 551-571. https://doi.org/10.1007/s10787-024-01605-w

Vancouver

Rodrigues DCDN, Porto JCS, Dos Santos IL, Filho JIAB, Ferreira PMP. Repositioning anthelmintics for the treatment of inflammatory-based pathological conditions. Inflammopharmacology. 2025;33(2):551-571. doi:10.1007/s10787-024-01605-w

BibTeX
@article{Rodrigues2025,
  author = {Rodrigues, Débora Caroline do Nascimento and Porto, Jhonatas Cley Santos and Dos Santos, Ingredy Lopes and Filho, José Ivo Araújo Beserra and Ferreira, Paulo Michel Pinheiro},
  title = {Repositioning anthelmintics for the treatment of inflammatory-based pathological conditions},
  journal = {Inflammopharmacology},
  year = {2025},
  volume = {33},
  number = {2},
  pages = {551--571},
  doi = {10.1007/s10787-024-01605-w}
}
Kostenlos starten →